Lead sponsor
Advanced Reconstructive Surgery Alliance
1 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
1
Trials led
1
Ongoing
110
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Early Phase 1
1
Trials by status
Recruiting
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Efficacy of GLP-1 Receptor Agonists in Treating Upper and Lower Extremity LymphedemaBMI ≥23Early Ph 1Recruiting110